SINOVAC BIOTECH LTD (SVA) Form 6-K — May 29, 2026

$SVAForm 6-KFiled May 29, 2026, 5:00 PM ET0001213900-26-062907Original filing

Sinovac Biotech Ltd. (SVA) announced it received a delisting determination letter from Nasdaq because it failed to timely file its 2025 Annual Report on Form 20-F. This follows a previous compliance exception granted in January 2026, which required the company to file its 2024 annual report and Q2 2025 interim financials by May 11, 2026, a requirement the company met. Despite regaining compliance for the prior period, the company is now subject to a mandatory one-year panel monitor.

Key figures

Hearing stay days: 22

AI analysis

Red flags5 · Pro

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

Upgrade to Pro · $49/mo billed annually

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.